Two Sigma Advisers’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-16,600
Closed -$23K 2547
2022
Q3
$23K Sell
16,600
-10,900
-40% -$21.3K ﹤0.01% 2434
2022
Q2
$60K Buy
27,500
+10,000
+57% +$23K ﹤0.01% 2458
2022
Q1
$56K Sell
17,500
-43,800
-71% -$157K ﹤0.01% 2572
2021
Q4
$257K Sell
61,300
-27,700
-31% -$155K ﹤0.01% 2191
2021
Q3
$723K Sell
89,000
-52,300
-37% -$425K ﹤0.01% 1763
2021
Q2
$1.07M Sell
141,300
-73,300
-34% -$618K ﹤0.01% 1606
2021
Q1
$1.86M Buy
214,600
+67,500
+46% +$643K 0.01% 1298
2020
Q4
$1.17M Sell
147,100
-47,900
-25% -$401K ﹤0.01% 1490
2020
Q3
$1.55M Buy
195,000
+57,100
+41% +$515K ﹤0.01% 1289
2020
Q2
$1.36M Buy
137,900
+27,400
+25% +$252K ﹤0.01% 1422
2020
Q1
$854K Sell
110,500
-27,200
-20% -$137K ﹤0.01% 1570
2019
Q4
$530K Buy
137,700
+31,100
+29% +$136K ﹤0.01% 1859
2019
Q3
$536K Sell
106,600
-14,600
-12% -$84.9K ﹤0.01% 1690
2019
Q2
$801K Sell
121,200
-10,200
-8% -$70.1K ﹤0.01% 1622
2019
Q1
$995K Sell
131,400
-8,000
-6% -$62.3K ﹤0.01% 1530
2018
Q4
$1.13M Sell
139,400
-28,900
-17% -$287K ﹤0.01% 1430
2018
Q3
$2.17M Sell
168,300
-45,851
-21% -$575K 0.01% 1187
2018
Q2
$2.44M Buy
+214,151
New +$2.03M 0.01% 1208

Other funds holding CTSO

Two Sigma Advisers's CTSO Position: Q4 2022 in Review

Two Sigma Advisers sold out of Cytosorbents Corp (CTSO) in Q4 2022, closing a stake of 16,600 shares — an estimated $23K sold.

Two Sigma Advisers first reported a position in CTSO in Q2 2018 and held it in 18 quarters. The position peaked at $2.44M in Q2 2018. 53 funds tracked by Wall St. Rank hold CTSO as of Q4 2022.

  • Two Sigma Advisers reported no remaining Cytosorbents Corp position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 16,600 Cytosorbents Corp shares in Q4 2022, an estimated $23K.
  • Two Sigma Advisers first reported a position in Cytosorbents Corp in Q2 2018 and held it in 18 quarters.
  • Two Sigma Advisers's Cytosorbents Corp position peaked at $2.44M in Q2 2018.
  • 53 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2022.

Based on Two Sigma Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.